Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
fda
3
×
ipo
life sciences
3
×
national blog main
startups
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
covid-19
deals
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
melinta therapeutics
national
national top stories
new york blog main
new york top stories
novartis
oric pharmaceuticals
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
ipo
3
×
bio
covid
developing
medicines
new
roundup
acquisitions
activity
announced
approvals
biogen
biotech
ceo
clamped
collabs
company
daniel
deal
debut
delays
economic
fast
fda
gilead
gilead’s
help
including
introduce
isn’t
late
lot
lyra
markets
million
month
nose
noses
oric’s
o’day
Language
unset
3
×
Current search:
unset
×
startups
×
" life sciences "
×
fda
×
ipo
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More